UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Mycoses, ISSN 0933-7407, 03/2021, Volume 64, Issue 3, pp. 252 - 256
epidemiology | invasive fungal disease | haematopoietic cell transplantation | acute myeloid leukaemia | incidence | acute lymphoid leukaemia | Life Sciences & Biomedicine | Dermatology | Mycology | Science & Technology | Autografts | Fusariosis | Chemotherapy | Candidiasis | Acute lymphatic leukemia | Leukemia | Aspergillosis | Transplantation | Myelodysplasia | Candidemia | Epidemiology | Neutropenia | Index Medicus
Journal Article
2.
Full Text
The infectious propagules of Aspergillus fumigatus are coated with antimicrobial peptides
Cellular microbiology, ISSN 1462-5814, 03/2021, Volume 23, Issue 3, pp. e13301 - n/a
fungal virulence | aspergillosis | defensin‐like peptide | Peptides | Asexuality | Virulence | Microbiomes | Fluorescence | Gene deletion | Antiinfectives and antibacterials | Spores | Deletion mutant | Water currents | Fungi | Air flow | Microorganisms | Defensins | Ecological niches | Yard waste | Energy dissipation | Dispersal | Aspergillosis | Antimicrobial peptides | Colonization | Mold | Propagules | Conidia | Index Medicus
Journal Article
American journal of respiratory and critical care medicine, ISSN 1073-449X, 02/2021, Volume 203, Issue 3, pp. 307 - 317
Lung Diseases, Fungal - diagnosis | Invasive Fungal Infections - epidemiology | Lung Diseases, Fungal - epidemiology | Humans | Middle Aged | Risk Factors | Male | Hospitalization | Invasive Fungal Infections - diagnosis | COVID-19 - mortality | Respiration, Artificial | COVID-19 - therapy | COVID-19 - complications | Female | Aged | Retrospective Studies | France | COVID-19 | Severe acute respiratory syndrome coronavirus 2 | Fungi | Intensive care | Pandemics | Risk factors | Index Medicus | Abridged Index Medicus | fungal infection | SARS-CoV-2 | aspergillus | Original | aspergillosis
Journal Article
Journal of clinical immunology, ISSN 0271-9142, 02/2021, Volume 41, Issue 2, pp. 427 - 440
Life Sciences & Biomedicine | Immunology | Science & Technology | Immunohistochemistry | Skin | Nucleotide sequencing | Analysis | Aspergillosis | DNA sequencing | Cell culture | Flow cytometry | Cytokines | Helper cells | Tissue culture | Leukocytes (mononuclear) | Lymphocytes T | Inflammation | Fungi | Lungs | Hyphae | Peripheral blood mononuclear cells | Skin diseases | Mutation | Skin lesions | Enzyme-linked immunosorbent assay | Index Medicus
Journal Article
01/2021, 615
Newsletter
01/2021, 1950
Newsletter
01/2021
Newsletter
Journal of fungi (Basel), 01/2021, Volume 7, Issue 1, p. 27
Life Sciences & Biomedicine | Microbiology | Mycology | Science & Technology | Drugs | Disease | Risk groups | Hematology | Laboratories | Myeloid leukemia | Invasiveness | Leukemia | Prophylaxis | Antifungal agents | Fungal infections | Epidemiology | Patients | Polymerase chain reaction | Hospitals | Surveillance | Aspergillosis | Biomarkers | Software | Acute myeloid leukemia | Deoxyribonucleic acid--DNA | Neutropenia | Greece | hematology patients | diagnosis | invasive aspergillosis | 2020 EORTC/MSGERC criteria
Journal Article
Emerging infectious diseases, ISSN 1080-6040, 01/2021, Volume 27, Issue 1, pp. 18 - 25
Infectious Diseases | Immunology | Life Sciences & Biomedicine | Science & Technology | Medical research | Coronavirus infections | Influenza | Lung diseases | Immunotherapy | Aspergillosis | Medicine, Experimental | Coronaviruses | Pharmaceutical industry | Posaconazole | Health aspects | Pulmonary aspergillosis | Risk factors | Diagnosis | Bronchoscopy | Intensive care | Severe acute respiratory syndrome | Antifungal agents | Inflammation | Fungal infections | Epidemiology | Patients | Cavitation | Inflammatory diseases | Severe acute respiratory syndrome coronavirus 2 | COVID-19 | Infectious diseases | Swine flu | Biomarkers | Viral infections | Index Medicus | Expedited | complications | zoonoses | respiratory infections | fungal infections | Aspergillus | SARS-CoV-2 | fungi | severe acute respiratory syndrome coronavirus 2 | Aspergillosis Complicating Severe Coronavirus Disease | aspergillosis | severe viral pneumonia | coronavirus disease
Journal Article
Journal of fungi (Basel), ISSN 2309-608X, 02/2021, Volume 7, Issue 2, p. 122
Pathogens | Postoperative period | Hematology | Syngeneic grafts | Mortality | Lung diseases | Prophylaxis | Lung transplantation | Cystic fibrosis | Fungal infections | Lung transplants | Epidemiology | Morbidity | Risk factors | Ischemia | Medical prognosis | Biomarkers | Mold | invasive fungal disease | invasive aspergillosis | lung transplantation | preemptive treatment | prophylaxis
Journal Article
Journal of fungi (Basel), 01/2021, Volume 7, Issue 1, p. 22
Life Sciences & Biomedicine | Microbiology | Mycology | Science & Technology | Proteins | Genotyping | Voriconazole | Aspergillosis | Mutation | Patients | Strains (organisms) | Deoxyribonucleic acid--DNA | Colonization | azole resistance mechanisms | hospital environment | Aspergillusfumigatus | cyp51A
Journal Article
Scientific reports, ISSN 2045-2322, 02/2021, Volume 11, Issue 1, pp. 3943 - 3943
Journal Article
Journal of fungi (Basel), ISSN 2309-608X, 02/2021, Volume 7, Issue 2, p. 152
Pathogens | Epidemics | Disease | Lung diseases | Virulence | Clinical isolates | Cystic fibrosis | Infections | Genetic diversity | Patients | Epidemiology | Genotype & phenotype | Tuberculosis | Genotyping | Aspergillosis | Evolution | Chronic illnesses | molecular epidemiology | genetic diversity | chronic pulmonary aspergillosis | Aspergillus fumigatus | genotyping
Journal Article
Archivos de bronconeumología (English ed.), 01/2021, Volume 57 Suppl 1, p. 11
Bronchitis - blood | Pandemics | COVID-19 Testing | Humans | Aspergillosis - diagnosis | Superinfection - diagnosis | Tracheitis - microbiology | Bronchitis - microbiology | Mannans - analysis | Bronchitis - diagnosis | COVID-19 - diagnosis | Tracheitis - diagnosis | Antigens, Fungal - blood | SARS-CoV-2 | COVID-19 - complications | Invasive Pulmonary Aspergillosis - blood | Influenza, Human - diagnosis | Anti-Bacterial Agents - adverse effects | COVID-19 - epidemiology | Aspergillosis - blood | Invasive Pulmonary Aspergillosis - epidemiology | Tracheitis - blood | Respiratory Distress Syndrome - etiology | Diagnosis, Differential | Risk Factors | Influenza, Human - epidemiology | Respiratory Distress Syndrome - epidemiology | Invasive Pulmonary Aspergillosis - diagnosis | Adrenal Cortex Hormones - adverse effects | Mannans - blood | Biomarkers | Sex Distribution | Bronchoalveolar Lavage Fluid - chemistry | Invasive Pulmonary Aspergillosis - complications
Journal Article
Journal of fungi (Basel), 01/2021, Volume 7, Issue 1, p. 17
Life Sciences & Biomedicine | Microbiology | Mycology | Science & Technology | Pathogens | Breakpoints | Pharmacodynamics | Candidiasis | Bacterial infections | Laboratories | Antifungal agents | Fungal infections | Epidemiology | Fungi | Minimum inhibitory concentration | Candidemia | Mold | Neutropenia | invasive candidiasis | minimal inhibitory concentration | invasive aspergillosis | clinical breakpoints | mucormycosis | therapeutic response
Journal Article
Journal of fungi (Basel), 01/2021, Volume 7, Issue 1, p. 4
Journal Article